BioPharma APAC

Bio Marketing

Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with Fos...

January 16, 2023 | News

Eisai Files Marketing Authorization Application for Anti-Amyloid-Beta Protofibril Antibody Lecanemab for Early Alzheimer's Disease in Japan

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Mass...

January 16, 2023 | News

GenNext Technologies Appoints Dr. Lisa Jones of UCSD to the Role of Chief Science Officer (CSO)

With ambitious plans to expand the reach and impact of their Flash Oxidation (Fox™) Protein Footprinting System beyond in vitro proteins,&n...

January 11, 2023 | News

CG Life and MC Services establish US-EU strategic partnership

-CG Life, an integrated digital marketing and PR agency supporting life sciences and healthcare companies, and MC Services AG, a major European P...

January 09, 2023 | News

Polysciences Announces New Bioprocessing Brand, Kyfora Bio

Building on Polysciences’ extensive experience in developing and manufacturing monomers, polymers, microspheres, and specialty reagents for the medic...

January 03, 2023 | News

Japan Ministry of Health, Labor and Welfare Approves Manufacturing and Marketing of Adtralza® (tralokinumab) in Japan for Adults with Atopic Dermatitis

Approval is a significant advancement for those patients in Japan who continue to suffer from the often-debilitating symptoms of atopic dermatitis and are ...

December 26, 2022 | News

Everest Medicines' Licensing Partner Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis

The European Medicines Agency (EMA) has also accepted the Marketing Authorization Application (MAA) for etrasimod in the same patient population with...

December 22, 2022 | News

Inventia enters into a distribution agreement for RASTRUM™ with SCRUM Inc in Japan

RASTRUM™, is a game-changing 3D cell culture platform that’s accelerating the quest to cure cancer and debilitating diseases. With applications...

December 05, 2022 | News

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

Obtained marketing approval on the 23rd (local time) from the Therapeutic Goods Administration (TGA) of Australia for the indication of gl...

November 25, 2022 | News

AcuCort signs its first commercial agreement for the company's drug Zeqmelit™

Kamada Ltd., a leading global biopharmaceutical company, has a well-established infrastructure for marketing, sales, and distribution of commercial pharmac...

November 24, 2022 | News

GenScript takes home Executive of the Year - Biotechnology at the SBR Management Excellence Awards 2022

Global biotechnology corporation, GenScript Asia Pacific's President, Mr. Johnson Wang bagged the Executive of the Year - Biotechnology title at ...

November 21, 2022 | News

MEDICOX Signs Contract with ORAMED to Distribute Oral Insulin in South Korea

MEDICOX secures distribution right for ORAMED's oral insulin in South Korea after phase 3 of FDA approval- Contract scale up to 18...

November 21, 2022 | News

Simcere and Idorsia enter into a licensing agreement for daridorexant in China

Jinsheng Ren,Chairman and CEO of Simcere commented: "This licensing agreement represents an important and exciting step in pursuing Simcere's mission of p...

November 16, 2022 | News

Twitter dissent hits Big Pharma.

After many days of unpredictability on Twitter, people easily dropped the stock of the pharmaceutical corporation Eli Lilly with a single message, demonstr...

November 15, 2022 | News

Stay Connected